R5V20227ForR4

Cross-version ValueSet R5.PHVSManufacturersOfVaccinesMVXCDCNIP for use in FHIR R4

activeExtensions for Using Data Elements from FHIR R5 in FHIR R40.1.055 concepts55 expanded

This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v2-0227|2.0.0` for use in FHIR R4.

Metadata

hl7.org/fhir
Canonical URL
http://hl7.org/fhir/uv/xver/ValueSet/R5-v2-0227-for-R4
ID
R5-v2-0227-for-R4
Name
R5V20227ForR4

http://terminology.hl7.org/CodeSystem/v2-0227

2.ext.055 codes
CodeDisplay
ABAbbott Laboratories
ADAdams Laboratories, Inc.
ALPAlpha Therapeutic Corporation
ARArmour
AVBAventis Behring L.L.C.
AVIAviron
BABaxter Healthcare Corporation
BAHBaxter Healthcare Corporation
BAYBayer Corporation
BPBerna Products
BPCBerna Products Corporation
CENCenteon L.L.C.
CHIChiron Corporation
CMPCelltech Medeva Pharmaceuticals
CNJCangene Corporation
CONConnaught
DVCDynPort Vaccine Company, LLC
EVNEvans Medical Limited
GEOGeoVax Labs, Inc.
GREGreer Laboratories, Inc.
IAGImmuno International AG
IMMerieux
IUSImmuno-U.S., Inc.
JPNThe Research Foundation for Microbial Diseases of Osaka University
KGCKorea Green Cross Corporation
LEDLederle
MAMassachusetts Public Health Biologic Laboratories
MBLMassachusetts Biologic Laboratories
MEDMedImmune, Inc.
MILMiles
MIPBioport Corporation
MSDMerck & Co., Inc.
NABNABI
NAVNorth American Vaccine, Inc.
NOVNovartis Pharmaceutical Corporation
NVXNovavax, Inc.
NYBNew York Blood Center
ORTOrtho-Clinical Diagnostics
OTCOrganon Teknika Corporation
OTHOther manufacturer
PDParkedale Pharmaceuticals
PMCsanofi pasteur
PRXPraxis Biologics
PWJPowderJect Pharmaceuticals
SCLSclavo, Inc.
SISwiss Serum and Vaccine Inst.
SKBGlaxoSmithKline
SOLSolvay Pharmaceuticals
TALTalecris Biotherapeutics
UNKUnknown manufacturer
USAUnited States Army Medical Research and Material Command
VXGVaxGen
WAWyeth-Ayerst
WALWyeth-Ayerst
ZLBZLB Behring